TLR9 agonist harnesses innate immunity to drive tumor-infiltrating T cell expansion in distant lesions in a phase 1/2 study of intratumoral IMO-2125+ipilimumab in anti-PD1 refractory melanoma patientsCara Haymaker,Marc Uemura,Wen-Jen Hwu,Ravi Murthy,Marihella James,Ankit Bhatta,Salah Eddine Bentebibel,Julie Brevard,James Geib,Kathryn Lipford,Mark Cornfeld,Srinivas Chunduru,Cassian Yee,Scott Woodman,Rodabe Amaria,Sapna Patel,Hussein Tawbi,Isabella Glitza Oliva,Michael Davies,Willem Overwijk,Patrick Hwu,Chantale Bernatchez,Adi DiabJOURNAL FOR IMMUNOTHERAPY OF CANCER（2017）引用 0|浏览27暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
